Lundbeck Set For 'Transformative' Eptinezumab Launch

February 21 PDUFA Date For Migraine Drug

 
• By Kevin Grogan
  
Lundbeck
Strong 2019 for the Danish pharma firm • Source: Lundbeck

More from Earnings

More from Business